Hepatitis C, Chronic: all 1,090 studies
Page 6 of 11. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyStatus unknownNCT03549312Phase 4
- People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsActive, not recruitingNCT03520660Phase 4
- Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS TaysideCompletedNCT03513796
- "Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in EgyptStatus unknownNCT03510637
- Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)TerminatedNCT03500562
- Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral InfectionsStatus unknownNCT03495570
- Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir CombinationCompletedNCT03490097Phase 2/3
- Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab ModelStatus unknownNCT03488485Not applicable
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1bCompletedNCT03485846Phase 2
- Re-treatment of HCV Following DAA FailureTerminatedNCT03483987Not applicable
- DAA Therapy in Pediatric Patients With Chronic Hepatitis CStatus unknownNCT03481036Not applicable
- Pathology of Hepatitis c NephropathyStatus unknownNCT03476031
- The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults SubjectsCompletedNCT03462173Phase 1
- Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational StudyStatus unknownNCT03461250
- Cohort Study on People Who Inject Drugs in SenegalStatus unknownNCT03459768
- Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis CCompletedNCT03453346Not applicable
- A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in ChinaCompletedNCT03430830Phase 1
- Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis CCompletedNCT03416491Phase 2
- Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected PatientsCompletedNCT03413696
- Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis CStatus unknownNCT03402165Phase 4
- Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4WithdrawnNCT03381859Phase 4
- Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based RegimensCompletedNCT03366610
- Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.CompletedNCT03362814Phase 2/3
- Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment EfficacyCompletedNCT03348059
- Side Effects After Direct-acting Antiviral TreatmentCompletedNCT03346941
- Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based SettingsCompletedNCT03343925
- Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C AdolescentsStatus unknownNCT03343444Phase 3
- Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed CryoglobulinemiaCompletedNCT03342261
- Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-relatedCompletedNCT03313154
- Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6CompletedNCT03303599
- Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without RibavirinCompletedNCT03283176
- Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral DrugsStatus unknownNCT03268317
- Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionCompletedNCT03248622
- Long Term Follow-up of Hepatitis C Cured PatientsCompletedNCT03246048
- Transforming the Cascade Of Hepatitis C CareCompletedNCT03226509
- Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1bStatus unknownNCT03222167Phase 3
- Study of AT-527 in Healthy and HCV-Infected SubjectsCompletedNCT03219957Phase 1
- Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus InfectionStatus unknownNCT03212833
- Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in AdultsWithdrawnNCT03208322
- The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAsCompletedNCT03188276Early Phase 1
- 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild FibrosisCompletedNCT03186365Phase 3
- Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in AdultsCompletedNCT03181074
- Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral DrugsStatus unknownNCT03170076
- Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for NonadherenceStatus unknownNCT03164902Not applicable
- Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus PatientsStatus unknownNCT03163849Phase 3
- Integrated Treatment of Hepatitis C Virus InfectionCompletedNCT03155906Not applicable
- Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) TherapyCompletedNCT03155113Not applicable
- Hepatitis C Virus Infection in Patients With HemoglobinopathiesCompletedNCT03149289
- Real World Experience of Chronic Hepatitis C (CHC) Treatment in IsraelCompletedNCT03144440
- Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)WithdrawnNCT03143998Phase 4
- A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5AWithdrawnNCT03105349Phase 4
- Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infectionCompletedNCT03098121Phase 4
- Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C TreatmentCompletedNCT03090035Phase 3
- Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis PatientsStatus unknownNCT03067883Phase 2
- Treating Hepatitis C in CRF Using Sofosbuvir and DaclatasvirCompletedNCT03063879Phase 4
- Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAsCompletedNCT03063723
- Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy PatientsCompletedNCT03057236Not applicable
- Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1BCompletedNCT03050905Phase 4
- Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based TreatmentStatus unknownNCT03042520
- Vertical Transmission of Hepatitis C in Adult Children of Female Baby BoomersCompletedNCT03038763
- Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis CStatus unknownNCT03022006Phase 4
- Curing HCV in Incarcerated PatientsStatus unknownNCT03018353Phase 4
- MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSVTerminatedNCT03003338Phase 4
- Anticipated and Perceived Benefits Following Hepatitis C TreatmentCompletedNCT03000023
- Metformin Therapy in HCV InfectionCompletedNCT02972723Phase 4
- Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted PatientsCompletedNCT02969668
- Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing WorldCompletedNCT02964091Phase 4
- Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in KoreaCompletedNCT02951364
- Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.Status unknownNCT02950870Phase 4
- Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2CompletedNCT02945228
- Triple Combination DAAs for Treating HCV GT1b SubjectsWithdrawnNCT02932293Phase 2
- Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaCompletedNCT02907996
- Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected PatientsStatus unknownNCT02897596Phase 3
- Regression of Liver Fibrosis After Daclatasvir and Asunaprevir TreatmentStatus unknownNCT02865369
- A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal ImpairmentCompletedNCT02864199Phase 4
- APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and RibavirinCompletedNCT02850289
- Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)WithdrawnNCT02806362Phase 3
- Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without InterferonCompletedNCT02804386Phase 4
- A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6TerminatedNCT02791256Phase 3
- Association of Vitamin D Binding Protein Polymorphisms With Response to HCV TherapyCompletedNCT02788682
- Hepatocellular Carcinoma in HIV-infected PatientsCompletedNCT02785835
- Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical PracticeCompletedNCT02783976
- Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCCCompletedNCT02771405Phase 3
- Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)Status unknownNCT02768545Phase 4
- Extrahepatic Insulin Resistance in Chronic Hepatitis CCompletedNCT02760355Not applicable
- Impact of Antiviral Therapy on Gastroesophageal Varices.CompletedNCT02758509
- Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)Status unknownNCT02745132Phase 4
- A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus InfectionCompletedNCT02716428Phase 2
- SR-BI and Antiviral Treatment Response in HCVCompletedNCT02714712
- Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune DiseaseStatus unknownNCT02691728Phase 4
- Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCVCompletedNCT02690103Phase 2
- HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-InfectionCompletedNCT02660905Phase 3
- Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis CStatus unknownNCT02639585Phase 4
- Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution TherapyStatus unknownNCT02638233Phase 4
- Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1CompletedNCT02629172
- Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)CompletedNCT02628717
- Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)CompletedNCT02624063Phase 4
- A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected PatientsStatus unknownNCT02617615Phase 1
- Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject DrugsCompletedNCT02609893Phase 4
- Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 InfectionCompletedNCT02597166Phase 3